Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 56 15
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 50 20
Regdanvimab Authorized Experimental Antiviral Jan/18/2023 6 5
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
T cells Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023 24 0
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022 63 3
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 7 18
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 15 20
Anti-spike nanobody-IFN-β conjugated exosomes Potential treatment - pre-clinical evidence Experimental Antiviral Sep/26/2022 1 0
IMAT-MSCs Potential treatment - pre-clinical evidence Experimental Other treatment Sep/23/2022 1 0
Excel (.xslx) CSV (.csv)